| The domestic pharmaceutical sector has outperformed the Sensex in 2010, recording a gain of about 34 per cent, making India an attractive destination for foreign players who have been looking to increase their exposure in one of the fastest growing healthcare markets globally. |
 |
| The size of the Indian drug retail market has crossed US$ 10.42 billion for the 12 months ended November 2010, according to the research firm, IMS Health Information and Consulting Services. Additionally, the number of foreign players investing and expanding their bases in India has been rampant enabling players to capture the forecasted double digit growth in the pharma market. |
|
| Significantly, the bar coding on all medicine packs meant for exports has been made mandatory by the union Minister of Commerce and will come into effect from July 1, 2011 to trace and track the medicines to its source of origin. |
|
| Top References: |
|
Domestic pharma biggies outperform sensex in '10
The Times of India: Feb 1, 2011 |
|
| The domestic pharmaceutical sector has outperformed the Sensex in 2010, recording a gain of about 34 per cent. India is estimated to be a US$ 12 billion market with strong growth in domestic formulations (medicines)... |
|
|
|
Drug retail sales up 18% in 2010 as cos take rural roads
The Economic Times: Jan 1, 2011 |
|
| Sales in the domestic drug retail market rose to a healthy 18.36 per cent during 2010, making India an attractive destination for foreign players who have been looking to increase their exposure in one of the fastest growing healthcare markets globally... |
|
|
|
Pharma, healthcare grew this year on M&As booster dose
CII: Dec 20, 2010 |
|
| Looking healthier on booster dose of global alliances, the Indian pharma and healthcare sectors repeatedly hit headlines this year on account of mergers and acquisitions (M&As)... |
|
|
|
India-Russia set $20 billion trade target in 5 years
CII: Dec 21, 2010 |
|
| India and Russia have set a target of more than quadrupling the bilateral trade to $20 billion in five years. The two countries identified pharmaceuticals, energy, IT & communication, chemicals & fertilisers and banking & finance as thrust areas in a protocol on trade and investment was signed... |
|
|
|
Global pharma companies' research widens scope for entrepreneurs
The Economic Times: Dec 17, 2010 |
|
| The clinical research organisations (CRO) business in India has increased 84 per cent during 2006-2008 as against the global average of 12 per cent. Furthermore, the market size of Site Management Organisations (SMOs) is almost 30 per cent of the US$ 110.25 million clocked by the CRO segment... |
|
|
|
US pharma cos show interest in setting up units in Guj
Business Standard: Dec 30, 2010 |
|
| Two US-based companies, Amneal Pharmaceuticals, LLC and Apicore, LLC have sent proposals to the Gujarat Food and Drugs Control Administration (FDCA) to set up units in the state... |
|
|
|
Indian drug market expected to be worth US$ 50 billion
OIFC: Apr 14, 2010 |
|
| India is estimated to become one of the top 10 drug markets with a worth of US$ 50 billion, in the next 10 years, according to a report by consultancy company PricewaterhouseCoopers (PwC). The country currently stands at 14th position in the list of world’s largest markets with annual sales of US$ 19 billion, as of March 2009... |
|
|
|
Merck sets up first custom-solutions unit in India
LiveMint: Jan 4, 2011 |
|
| German pharmaceuticals and chemicals group, Merck KgaA has set up its first laboratory - chemicals and technology solutions centre in India offering customised services for its local as well as foreign clients in pharma, bio-technolgy, cosmetics and other chemistry-based industries... |
|
|
|
Wellcome, Merck JV to make anti-diarrhoea vaccine for babies
The Economic Times: Jan 25, 2011 |
|
| An Indian healthcare joint venture (JV) between drugmaker Merck & Co and UK-based charitable entity, Wellcome Trust plans to develop heat stable oral rotavirus vaccine to prevent diarrhoea in babies in developing countries... |
|
|
|
Lincoln Pharma wins patent for NDDS
Business Standard: Jan 19, 2011 |
|
| Lincoln Pharmaceuticals Ltd (LPL) has received a patent for a Nasal Drug Delivery System (NDDS) in India that will particularly help in chemotherapy induced nausea... |
|
|
|
SBI, MSIF jointly invest Rs 580 cr in MP power plant
LiveMint: Jan 12, 2011 |
|
| Macquarie SBI Infrastructure Fund (MSIF) and the State Bank of India (SBI) have together invested Rs 580 crore (US$ 128.50 million) in a Moser Baer Projects Pvt Ltd power plant at Anuppur in Madhya Pradesh (MP). |